Oct. 20, 2009 (Business Wire) -- The Board of Directors of IMS Health (NYSE: RX) today declared a regular fourth-quarter 2009 dividend of $0.03 per share, payable on December 4, 2009 to shareholders of record at the close of business on November 6, 2009.

Operating in more than 100 countries, IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.3 billion in 2008 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations, including product and portfolio management capabilities; commercial effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve productivity and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.